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Abstract
Introduction: PCR detection offers a good opportunity to obtain fast results which is a priority in tuberculosis control programs. 
Objectives: We assayed an in-house PCR method based on the detection of mycobaterial IS6110 gene in clinical samples of patients with pulmonary and 
extrapulmonary tuberculosis to demonstrate its usefulness and reliability in the setting of a middle-resource region with high tuberculosis prevalence. 
Materials and methods: Pulmonary (n=317) and extrapulmonary (n=41) samples were collected from 358 patients with clinical suspicion of tu-
berculosis. All samples were processed to detect acid-fast bacilli by microscopy, culture on solid media and PCR. To remove PCR inhibitors, three 
washing steps of the decontaminated pellet were included before mycobacterial cell lysis. 
Results: 7KHRYHUDOOVHQVLWLYLW\ZDVLQFOLQLFDOVDPSOHVDQGVSHFLÀFLW\ZDVIRURXULQKRXVHPHWKRGLQSXOPRQDU\DQGH[WUDSXOPRQDU\VDPSOHV
No inhibition was found among samples that were PCR negative, but culture positive for Mycobacterium tuberculosis. No false positives were found. 
Conclusions:,QKRXVH3&5LQDPLGGOHLQFRPHVHWWLQJUHJLRQZLWKVLPSOHDQGVWULFWO\FRQWUROOHGPHWKRGVFRXOGHIÀFLHQWO\FRPSOHPHQWFRQYHQ-
tional bacteriological tools for the rapid diagnosis of tuberculosis, especially in paucibacillary and extrapulmonary samples.
Key words: Tuberculosis, Polymerase Chain Reaction, pulmonary tuberculosis, Mycobacterium tuberculosis.
Resumen 
Introducción. La prueba de PCR ofrece la posibilidad de obtener resultados rápidos, una prioridad para los programas de control de la tuberculosis. 
Objetivos.Evaluar el método de PCR basado en la detección del gen IS6110 de las micobacterias en muestras clínicas de pacientes con tuberculosis 
SXOPRQDU\H[WUDSXOPRQDUSDUDGHPRVWUDUVXXWLOLGDG\FRQÀDELOLGDGHQXQVLWLRGHGHVDUUROORPHGLRFRQDOWDSUHYDOHQFLDGHWXEHUFXORVLV
Materiales y métodos. Se recolectaron 317 muestras pulmonares y 41 de origen extrapulmonar, de 358 pacientes con sospecha clínica de tubercu-
losis. Todas las muestras se procesaron para detectar bacilos ácido-alcohol resistentes por microscopía, cultivo en medio sólido y PCR. Para eliminar 
los inhibidores de la PCR se lavaron tres veces antes de realizar la lisis de la pared de la micobacteria.
Resultados. /DVHQVLELOLGDGWRWDOIXHGH\ODHVSHFLÀFLGDGGHSDUDHVWHPpWRGR´FDVHURµHQPXHVWUDVSXOPRQDUHV\H[WUDSXOPRQDUHV1R
se encontró inhibición entre las muestras que fueron negativas por PCR pero con cultivo positivo para Mycobacterium tuberculosis. No se hallaron 
falsos positivos.
Conclusiones. La implementación de la PCR “casera” en regiones de desarrollo intermedio como método simple y estrictamente controlado, podría 
FRPSOHPHQWDUHÀFLHQWHPHQWHODVKHUUDPLHQWDVEDFWHULROyJLFDVWUDGLFLRQDOHVSDUDHOGLDJQyVWLFRUiSLGRGHODWXEHUFXORVLVHVSHFLDOPHQWHHQPXHV-
tras paucibacilares y de origen extrapulmonar.
Palabra clave: tuberculosis, reacción en cadena de la polimerasa, tuberculosis pulmonar, Mycobacterium tuberculosis
Introduction
Tuberculosis is still a serious public health pro-
blem in many countries even with the existence 
of preventive measures to avoid its increase in 
the community. In Colombia, 11,047 new cases 
of tuberculosis (24.2 cases per 100,000 popula-
tion) were reported (1). In Armenia (296,000 inha-
bitants), a city located at the central western part 
of Colombia, reported an incidence of 62.6 new 
cases per 100,000 population during 2009, com-
pared with the national rate of 24.26 per 100,000; 
consequently, this geographic area has been clas-
VLÀHGDVDKLJKSUHYDOHQFHDUHDIRUWXEHUFXORVLV(2). 
5HFLELGR$FHSWDGR
&RUUHVSRQGHQFLD-RUJH*yPH]0DUtQ*(3$02/&HQWURGH
,QYHVWLJDFLRQHV%LRPpGLFDV8QLYHUVLGDGGHO4XLQGtR$YHQLGD
%ROtYDU1$UPHQLD&RORPELD'LUHFFLyQHOHFWUyQLFD
JHSDPRO#XQLTXLQGLRHGXFR
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Additionally, multidrug-resistant strains increa-
sed notoriously in 2006-2008 in many cities of 
the country, including Armenia, with 0.5-2.2% (3). 
There is a great concern of public health autho-
rities about the dissemination of these strains, 
and they have urged the need for early diagno-
sis of active cases.
 
Rapid diagnosis of mycobaterial infections is cu-
rrently based on slide examination of acid fast 
bacilli (4). This procedure is not very sensitive, 
especially in paucibacillary clinical samples and 
does not discriminate between Mycobacterium 
tuberculosis and other Mycobacterium species, 
like M. avium, a frequent cause of mycobacterial 
infection in immunosupressed patients (5).
 
Mycobacteria culture remains the gold stan-
dard for diagnosis, but it is expensive and de-
PDQGV PRUH WKDQ  ZHHNV WR REWDLQ D GHÀ-
QLWLYHLGHQWLÀFDWLRQ7KHUHDUHFRQFHUQVDERXW
the availability of commercial PCR methods 
in poor and middle-income countries becau-
se in-house PCR assays produce highly varia-
EOH HVWLPDWHV RI VHQVLWLYLW\ DQG VSHFLÀFLW\ (6). 
A previous meta-analysis of various protocols 
for PCR-based diagnosis of pulmonary tuber-
FXORVLVLGHQWLÀHGDIHZIDFWRUVDVVRFLDWHGZLWK
improved diagnostic accuracy, and others that 
did not make a substantial difference and re-
commended that future development of PCR 
tests, to detect M. tuberculosis from sputum 
specimens, should take into consideration 
these test characteristics as a way of impro-
ving the accuracy of in-house tests to diagno-
se pulmonary tuberculosis (7, 8).
Therefore, we standardized and evaluated an 
in-house simple PCR method for the detection 
of the IS6110JHQVSHFLÀFIRUMycobacterium tu-
berculosis complex and demonstrated that it is 
a feasible, rapid and economic method that can 
be applied in local conditions in a regional labo-
ratory in highly endemic areas.
Material and methods
Ethical aspects, patients, and clinical speci-
mens: Patients were informed about the study, 
and written informed consents were obtained 
for each one of them or their next of kin, accor-
ding to the regulation number 008430 of 1993 
of the Ministry of Health of Colombia. 
Clinical samples were collected prospectively 
and consecutively from all patients with clinical 
suspicion of tuberculosis from January to De-
cember 2007. Patients were admitted to the Uni-
versity Hospital “San Juan de Dios” in the city of 
Armenia. Patients included in this study were not 
likely to be HIV positive. 
From the 358 clinical specimens, 227 were spu-
WXP  ZHUH EURQFKRDOYHRODU ODYDJH ÁXLG 
ZHUH EORRG  ZHUH JDVWULF ÁXLG DVSLUDWH 
ZHUH XULQH  ZHUH FHUHEURVSLQDO ÁXLG  ZHUH
DVFHWLFÁXLGDQGZHUHDEVFHVVVHFUHWLRQV$OO
samples, except blood, were stained by the Zie-
hl-Nielsen smear technique and examined for 
the presence of acid fast bacilli (AFB) according 
to standardized methods (9). All clinical speci-
mens were processed in the Centro de Investi-
gaciones Biomédicas, Universidad del Quindío. 
Clinical diagnosis of tuberculosis was establis-
hed by patient histories, clinical and radiological 
ÀQGLQJVDQGUHVSRQVHWRDQWLWXEHUFXORVLVGUXJ
therapy. Response to antituberculosis treatment 
was recorded according to national guidelines 
(10). Only good quality sputum samples belon-
ging to HIV-negative patients were studied. True 
positive samples were positive for M. tuberculo-
sis in culture with or without AFB smear positive 
or were AFB positive with a negative culture, but 
patients showed a good clinical and radiogra-
phical response to antituberculosis treatment. 
All samples with negative cultures for mycobac-
teria or with positive AFB, but with no response 
to antituberculosis treatment were considered 
true negatives for M. tuberculosis.
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Specimen processing: Sputum and urine sam-
ples were diluted v/v in 10% sodium phospha-
te buffer, incubated during 2 hours, and then 
homogenized in vortex and concentrated by 
centrifugation (4,000g for 30 minutes). Bron-
FKRDOYHRODU ODYDJH ÁXLG VDPSOHV ZHUH WUHDWHG
with 10% sodium phosphate v/v, incubated du-
ring 2 hours and then homogenized in vortex 
and concentrated by centrifugation (1,500g, 10 
minutes). Supernatant was recovered and cen-
trifuged (4,000g, 30 minutes). Pellet was suspen-
ded in water again and divided in two aliquots 
for DNA extraction and culture. Blood samples 
were centrifuged (1,500g, 10 minutes), then the 
red blood cells were discarded and 0.4% sodium 
deoxicholate was added and the mixture was in-
cubated during 30 minutes at room temperatu-
re. After this, the mixture was divided in aliquots 
for PCR and culture. Pellet was suspended again 
in 400 μl of TE buffer 1x (10 mM Tris-HCl pH 8,0 
/ EDTA 1,0 mM) and the tube was placed in a 
boiling water bath for 20 minutes according to 
national guidelines for tuberculosis laboratory 
techniques (11). 
DNA extraction:  ǌO RI VDPSOH VXVSHQGHG
for a second time in TE buffer were added to 
ǌORI O\VR]\PHPJPODQG LQFXEDWHGIRU
KRXUVDW&7KHQǌORISURWHLQDVH.
mg/ml) were added and incubated for 10 mi-
nutes at 65°C to inactivate DNase and RNases. 
$IWHU WKDW ǌO 6'6  &7$%1D&O 
M were added to dissolve the polysaccharides 
of cell walls of mycobacteria and incubated for 
PLQXWHVDW&DQGǌORI FKORURIRUP
isoamil (24:1) were added and then centrifuged 
12,000g for 15 minutes at room temperature. 
6XSHUQDWDQW ZDV UHFRYHUHG DQG  ǌO RI LVR-
propanol were added and incubated for 1 hour 
at -20°C and then centrifuged for 15 minutes 
12,000g at 4°C. Finally, the DNA was precipitated 
with 1 ml ethanol, washed twice and suspended 
again in 25 ml TE buffer (10 mM TRIS-HCl pH 8,0 
/ 1,0 mM EDTA). One sample without template 
ZDVSURFHVVHG LQǌORI 7(DV D FRQWURO IRU
contamination during the extraction step.
Mycobacterium tuberculosis culture and iden-
WLÀFDWLRQ: M. tuberculosis cultures were derived 
from clinical samples. Samples were treated with 
NaOH and inoculated by duplicate in Lowens-
tein-Jensen and Ogawa-Kudoh medium (LJ-OK) 
using standard procedures. Growth assessment 
was performed at two, four, six and eight weeks. 
,GHQWLÀFDWLRQRIP\FREDFWHULDVSHFLHVZDVFDUULHG
out by using conventional phenotypic tests (12).
PCR procedure: A reaction mixture of 50 μl con-
taining 5 μl of primers (0.5 μmol each INS-1 1 
5’–CGTGAGGGCATCGAGGTGGC-3’ and INS-2 
5’-GCGTAGGCGTCGGTGACAAA-3’), 5 μlTaq po-
lymerase buffer 10x (25 mM Tris HCl [pH 9,5], 
50 mM KCl, 10 mM MgCl2, 1 mM dithiothreitol, 
bovine serum albumin [1 mg/ml], 4 μl of dNTPs 
2.5mM, 3 μl of MgCl2 25mM, 0.25 μl of Tucan Taq 
DNApol and 2 μl of DNA and 25.7 μl of water). 
The DNA was denatured for 5 minutes at 94°C 
IROORZHGE\DPSOLÀFDWLRQ F\FOHVZLWKDQDX-
tomated thermal cycler. Each cycle consisted of 
denaturation at 94°C for one minute, annealing 
of primers at 68°C for one minute, and primer 
extension at 72°C for two minutes. Presence of 
WKHESDPSOLÀFDWLRQSURGXFWZDVDQDO\]HGE\
HOHFWURSKRUHVLVRIORIWKHDPSOLÀHGPL[WXUHRQ
a 1.5% agarose gel. The DNA was stained by ethi-
dium bromide and photographed on a UV transi-
lluminator (13, 14)$PSOLÀFDWLRQSURWRFROGHWHFWHG
DNA amounts of tuberculous mycobacteria hig-
her than 50 fg (theoretically about 10 bacilli). A 
245 bp strong band at different concentrations of 
genomic M. tuberculosis DNA was observed.
Evaluation of inhibition of PCR: All available 
specimens that were positive for M. tuberculo-
sis growth but negative by PCR, and a group of 
randomly selected AFB culture positive and ne-
gative specimens, were analyzed for inhibition 
RI3&57KLVZDVEULHÁ\DFKLHYHGE\SHUIRUPLQJ
a second PCR on these lysates, under the con-
ditions described above, but with the addition 
of known template and primers. The detection 
limit of PCR was determined by preparing 10-
fold serial dilutions of M. tuberculosis DNA con-
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taining between 50 ng and 5 fg. Ten microliters 
IURPHDFKGLOXWLRQZHUHXVHG IRU DPSOLÀFDWLRQ
as described above. A duplicate of each DNA 
extract was spiked with approximately 0.5 pg of 
M. tuberculosis DNA from the H37Rv reference 
strain as recommended by Kunakorn (15).
Statistical methods and criteria for diagno-
sis evaluation: The chi square test was used to 
DQDO\]HUHVXOWV&RQÀGHQFHLQWHUYDOVZHUHFDOFX-
lated for 95%. Statistical analysis was carried out 
with the Epi-info software, version 3.5.1 (CDC, 
$WODQWD6HQVLWLYLW\VSHFLÀFLW\SRVLWLYHSUHGLFWL-
ve value, and negative predictive value were cal-
culated according to applicable tables.
 
Cost estimates: A global evaluation was per-
formed based on data from the account de-
partment at the Hospital San Juan de Dios, in 
Armenia based on reported mean costs of hos-
pitalization for 2008.
Results 
In total, 354 samples were analyzed by AFB and 
culture, and 4 blood samples were analyzed only 
by culture and PCR. In these samples, 62 were 
culture positive for M. tuberculosis and among 
them, 12 were AFB negative (Table 1). 
In seven patients, the culture was not perfor-
med due to a low sample amount or because 
results were non interpretable due to bacterial 
contamination, but with positive AFB smear and 
good response to antituberculosis treatment, 
they were also considered as true positive pa-
WLHQWVZLWKWXEHUFXORVLVFRQÀUPHGSDWLHQWVZLWK
tuberculosis). Consequently, the group of to-
tal true positive patients with tuberculosis was 
constituted by 62 patients M. tuberculosis culture 
positive and 7 patients with good response to 
VSHFLÀFDQWLWXEHUFXORVLV WKHUDS\ WRWDOSDWLHQWV
69, Table 2).
$PSOLÀFDWLRQ RI  ES IUDJPHQW RIM. tuber-
culosis DNA was positive in 66 clinical samples 
between 358 tested (Figure 1). The comparison 
RI WKH DPSOLÀFDWLRQ ZLWK $)% DQG FXOWXUHV DUH
summarized in Table 1. Discrepant results in the-
se samples were: two sputum samples and one 
EURQFKRDOYHRODUODYDJHÁXLGWKDWZHUH3&5QHJD-
tive and culture positive, and two urine samples 
that were PCR positive, AFB negative and culture 
positive. Two blood samples were PCR positive, 
but no reliable culture result was obtained becau-
se there was bacterial contamination. PCR overall 
VHQVLWLYLW\ZDV,&DQGVSHFLÀ-
city was 100% (IC 95% 99-100) (Table 2).
$VLJQLÀFDQWDPRXQWRIFDVHVZLWKWXEHUFXORVLV
in the city of Armenia show a strong demand for 
third level medical care, which demonstrates the 
existence of a delayed diagnosis (16). As a con-
VHTXHQFHSDWLHQWVVKRZHGDVLJQLÀFDQWSK\VLFDO
deterioration and a prolonged hospitalization 
period, which in turn increased the costs signi-
7DEOH/DERUDWRU\FKDUDFWHULVWLFVRIFOLQLFDOVDPSOHVDQGFRQÀUPHGWXEHUFXORVLVSDWLHQWV
Sample type Samples (n)
AFB*
positive/ culture 
positive
AFB negative/
culture positive
PCR positive
Samples with bacterial 
contamination during culture 
(n)
Sputum 227 27 4 33 5
Bronchoalveolar- lavage 90 19 3 21 0
Gastric aspirate 12 0 2 2 0
Urine 15 0 2 2 0
Lymph secretion 4 3 0 3 0
CSF** 3 0 1 2 0
$VFLWLFÁXLG 3 1 0 1 0
Blood 4 0 0 2 2
Total 358 50 12 66 7
$)%DFLGIDVWEDFLOOL&6)FHUHEURVSLQDOÁXLG
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Àcantly. We estimated the hospitalization cost 
for the different types of tuberculosis as ranging 
from US$ 527 to US$ 10,883, with an average 
of US$ 4,623 per case; and hospitalization time 
varied between 4 and 54 days.
Discussion
7XEHUFXORVLVGLDJQRVLV LVGHÀQLWLYHO\HVWDEOLVKHG
if the mycobaterial culture is positive, but this 
needs a long period to be able to obtain results 
(2 to 8 weeks). Additionally, 5-10% of cultures are 
negative, due to many factors as the low amount 
of bacilli, the non-viability of mycobacteria after 
decontamination procedure or the culture conta-
mination with other bacteria (17). These conditions 
could explain the loss of 11% of our cultures. 
Moreover, the delayed diagnosis of tuberculosis 
delays treatment, aggravating the health condi-
tion of patients and raising the transmission risk. 
Although an AFB test positive is useful to detect 
paucibacillary cases, this assay is not sensitive 
enough as illustrated by 19% of our cases that 
were AFB smear test negative and culture posi-
tive. Other studies report similar results ranging 
between 20 and 50% of false negatives (7).
'1$DPSOLÀFDWLRQE\3&5LVDUDSLGDQGVHQVLWLYH
method for the detection of M. tuberculosis in cli-
QLFDOVDPSOHV2QHRIWKHPRVWLPSRUWDQWPRGLÀ-
cations that we ensured was to introduce a boiling 
VWHSWKDWVLPSOLÀHVWKHPHWKRG3UHYLRXVVWXGLHV
have been retrospective in nature, focusing pri-
marily on the determination of assay performan-
ce. We undertook a prospective study to examine 
the impact of molecular testing for tuberculosis 
LQDQHIIRUWWREHWWHUGHWHUPLQHWKHEHQHÀWVDQG
impact on patient care. PCR testing implemen-
tation on the initial two sputum samples collec-
WHG GXULQJ WKH ÀUVW  KRXUV RI KRVSLWDOL]DWLRQ
would allow a faster diagnosis of tuberculosis. In 
WKLVZD\DVSHFLÀFFOLQLFDOPDQDJHPHQWFRXOGEH
rapidly implemented. In practice, smear-positive 
patients with a positive PCR indicate that the my-
cobacterial species is M. tuberculosis, and patients 
would be appropriately isolated and treated until 
their sputum samples became smear negative (18). 
Otherwise, a negative result would indicate the 
presence of a nontuberculous mycobacterial in-
fection, and the patient could be released from 
isolation and treated more appropriately. Poten-
tial for positive impact on patient care with a re-
duction in the cost of care is apparent (19).
 
PCR may be useful in the diagnosis of extrapul-
monary tuberculosis infections, particularly for 
meningitis. In our series, we found 17 cases with 
positive PCR, but AFB smear negative result. This 
is an important issue in the diagnosis of patients 
with clinical symptoms of tuberculosis. We found 
a 96% sensitivity, a very good result compared to 
previous papers of in-house PCR methods that re-
ported sensitivities between 53 and 73% (20). 
7DEOH6HQVLWLYLW\DQGVSHFLÀFLW\RI,63&5WHVW
&RQÀUPHG
tuberculosis
&RQÀUPHG
negative 
tuberculosis
PCR
Positive 66 0
Negative 3 289
Total 69 289
Sensitivity: 96%; positive predictive value: 1: negative predictive value: 
0.98
Figure 1. IS6110DPSOLÀFDWLRQRI Mycobacterium tuberculosis in 
clinical samples with AFB positive. M) Molecular marker weight 
100 pb (Promega); 1-5) sputum samples; 6) positive control; 8-9) 
QHJDWLYHFRQWURORIDPSOLÀFDWLRQDQGH[WUDFWLRQUHVSHFWLYHO\
245 pb
M 1 2 3 4 5 6 7 8 9
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PCR inhibition, a frequent phenomenon in blood 
samples, was controlled in our method (21, 22). 
%URQFKRDOYHRODUÁXLGDQGXULQHVDPSOHVGLGQRW
VKRZSUREOHPVRIVSHFLÀFLW\7KHXULQHVDPSOH
was from a patient with pulmonary tuberculosis 
and sputum AFB smear test was negative. Urine 
samples are easily obtained and they seem very 
XVHIXOWRFRQÀUPWXEHUFXORVLVEHIRUHLWLVFRQÀU-
med to be positive by culture.
Many cases of tuberculosis were diagnosed only 
by PCR. A blood sample was obtained in one 
patient with disseminated tuberculosis. In this 
case, the culture was contaminated with other 
organisms and diagnosis was reached only by 
PCR. Also, one of the urine samples came from a 
patient with pulmonary form and acid fast bacilli 
smear test negative. In another case, the urine 
sample came from a patient with acid fast bacilli 
smear test positive. PCR value on blood samples, 
and urine in pulmonary and extrapulmonary 
IRUPVRIWXEHUFXORVLVFDQEHVLJQLÀFDQWZKHQLW
LVGLIÀFXOWWRREWDLQJRRGTXDOLW\VDPSOHV(4, 5, 6, 7).
There is some debate about the use of IS6110 
as a target for M. tuberculosis PCR because, in 
some regions, strains lacking this element can 
be up to 20% (23). In Colombia, one study found 
7% of strains without this element (24). However, 
a previous study in the Quindío region reported 
the presence of this element in 27 M. tuberculo-
sis strains (25).
 
Many variations on the use of PCR diagnosis have 
been described, some for commercial methods 
and others for in-house methods. Commercial 
methods tend to be advantageous because re-
sults can be obtained within 4-6 hours. Howe-
ver, costs for these commercial methods are 
expensive and require special equipment. Our 
in-house method requires two days and multi-
ple steps in the process of sample preparation, 
VXFKDVH[WUDFWLRQDQG'1$SXULÀFDWLRQ+RZH-
ver, this represents an advantage over commer-
cial methods that use lysis buffers that are not 
very effective and have high levels of inhibition 
for Taq polymerase enzyme. The protocol used 
in our in-house method, including incubation 
with lysozyme during a long time (12 hours) and 
'1$SXULÀFDWLRQZLWKFKORURIRUPLVRDP\ODOFR-
hol and ethanol, ensures a greater lysis of myco-
bacteria and less inhibition. Thus, this protocol 
obtains a highly pure DNA of good quality (not 
degraded by nucleases) that is enough for am-
SOLÀFDWLRQDQGZLWKRXWLQKLELWRUV
One critical aspect of in-house methods is the 
control of the contamination of the PCR reac-
tion. We included negative controls for extrac-
WLRQDQGDPSOLÀFDWLRQVWHSVWRDYRLGIDOVHSRVLWL-
ves due to exogenous contamination. With the-
se precautions, we suggest that the test is appli-
FDEOH LQRXU ODERUDWRU\IRUWKH LGHQWLÀFDWLRQRI
M. tuberculosisLQFOLQLFDOVDPSOHVWRFRQÀUP$)%
smear-positive results. 
,QVXPPDU\QXFOHLFDFLGDPSOLÀFDWLRQDVVD\VFDQ
be used on smear positive sputum samples and 
potentially on smear negative samples, if the cli-
nical presentation is highly suggestive of tuber-
culosis. The most important application of our in-
house PCR that targeted IS6110VSHFLÀFJHQRPLF
elements of M. tuberculosis is a rapid diagnosis 
FRQÀUPDWLRQRIFOLQLFDOVDPSOHVIURPSXOPRQDU\
and extrapulmonary samples of cases with clini-
cal suspicion of tuberculosis. In extrapulmonary 
samples, its sensitivity is the major advantage of 
PCR, and we showed that it can detect amounts 
of mycobacteria as low as 10 bacilli.
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